Delivery Order SPE2DB20D2104-SPE2DB23FS10J
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The delivery order is for the supply of difluprednate 0.05% eye drops in 5 ml containers, with a ceiling value of $3,965.92 and a completion date of March 8, 2023. The contract was awarded on a full and open competition basis, without any set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,004.96, is for the delivery of Difluprednate 0.05% eye drops in 5 milliliter vials. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary of...
- This award from the Defense Logistics Agency (DLA) is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Difluprednate 0.05% eye drops in 5 mL packaging, with a ceiling value of $2,286.72 and a performance period through February 23, 2023. This contract does not have a...
- This federal contract award, valued at $11,601.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Difluprednate 0.05% eye drops in 5 ml bottles. This contract is a delivery order and has a firm fixed price pricing type, with a completion date of May 15, 2023. The contract was awarded on May 12, 2023 and does not have a set-aside designation, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. The contract has a ceiling value of $6,885.32 and runs through November 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops in 5ml vials. The contract award, valued at $1,609.29, has an ultimate completion date of January 17, 2023. This contract is a child order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML. The contract has a ceiling value of $1,241.12 and is a firm fixed price arrangement. It is funded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,680.85, is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award, valued at $11,003.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a completion date of January 16, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML. The $2,877.51 firm fixed-price delivery order has a completion date of March 10, 2023 and was awarded on March 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS10JDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Difluprednate 0.05% eye drops, a pharmaceutical product, with a ceiling value of $2,017.39. The contract is a firm fixed-price Delivery Order type with a completion date of February 8, 2023. There is no set-aside designation noted for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier of medical products to various federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 2/7/23 |